Clinical Trial 48275

Fort Lauderdale, FL 33319


Segal Trials is currently conducting a study evaluating the safety, effectiveness, and tolerability of two different dosages of the opioid use disorder (OUD) medication, SUBLOCADE® (extended-release buprenorphine). SUBLOCADE is currently approved to suppress withdrawal signs and symptoms in patients who have opioid use disorder.

Taking part in this study will provide information about the best maintenance dosage of SUBLOCADE for those who are seeking treatment for opioid use disorder and have high-risk opioid use.

Qualified Participants Must:

  • Are 18 years of age or older
  • Have moderate to severe opioid use disorder and have high-risk opioid use
  • Are not currently receiving treatment for opioid use disorder
  • Are seeking medical treatment for opioid use

Qualified Participants May Receive:

  • All study-related medication
  • Study-related medical assessments, monitoring, and counseling by a healthcare professional
  • Compensation for qualified participants
  • Assistance with travel expenses

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.